Chris Lewis
Stock Analyst at Roth Capital
(3.09)
# 1,306
Out of 5,036 analysts
13
Total ratings
77.78%
Success rate
62.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chris Lewis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGNT Cognyte Software | Reinstates: Buy | $4 | $8.13 | -50.80% | 5 | Nov 8, 2017 | |
| IRMD IRADIMED CORPORATION | Reinstates: Buy | $16 | $75.49 | -78.81% | 3 | Oct 31, 2017 | |
| AXGN Axogen | Initiates: Buy | $15 | $17.49 | -17.10% | 1 | Mar 6, 2017 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $63.41 | - | 3 | Feb 22, 2017 | |
| IRIX IRIDEX | Initiates: Buy | $20 | $1.08 | +1,751.85% | 1 | Dec 21, 2016 |
Cognyte Software
Nov 8, 2017
Reinstates: Buy
Price Target: $4
Current: $8.13
Upside: -50.80%
IRADIMED CORPORATION
Oct 31, 2017
Reinstates: Buy
Price Target: $16
Current: $75.49
Upside: -78.81%
Axogen
Mar 6, 2017
Initiates: Buy
Price Target: $15
Current: $17.49
Upside: -17.10%
Exact Sciences
Feb 22, 2017
Upgrades: Buy
Price Target: n/a
Current: $63.41
Upside: -
IRIDEX
Dec 21, 2016
Initiates: Buy
Price Target: $20
Current: $1.08
Upside: +1,751.85%